Ridker, Paul M <br/><br/>
A tale of three labels: translating the JUPITER trial data into regulatory claims.  [electronic resource] 

 -  Clinical trials (London, England)  Aug 2011 
 - 417-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1740-7753 
<br/><br/><label>Standard No.: </label>10.1177/1740774511407939  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Canada<br/>Cardiovascular Diseases--prevention & control<br/>Drug Labeling--legislation & jurisprudence<br/>Drug and Narcotic Control<br/>Europe<br/>Female<br/>Fluorobenzenes--therapeutic use<br/>Government Regulation<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Male<br/>Middle Aged<br/>Pyrimidines--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Rosuvastatin Calcium<br/>Sulfonamides--therapeutic use<br/>Translational Research, Biomedical<br/>United States<br/>United States Food and Drug Administration